Joel Poder

Medical Physicist at St George Cancer Center, Sydney. Special interest in brachytherapy. Opinions are my own and not the views of my employer

[Joel Poder @JPoderMedPhys]

@SamuelChaoMD @DanTrifMD @ISRSy This was a fantastic talk in what was a fantastic session

[Joel Poder @JPoderMedPhys]

Fantastic long term data for HDR boost. Very interesting to see lower side effect profile for TRUS based over CT based planning. More confidence in contouring or greater certainty in needle positioning at time of treatment? @agomeziturriaga @KamravaMD

[URONCOR @URONCOR]

¡Otro gran trabajo en #ESTRO2026! Compartimos los resultados a largo plazo de la braquiterapia HDR boost en cáncer de próstata (TC based vs TRUS). Datos robustos con más de 10 años de seguimiento medio que avalan un excelente control y supervivencia de los pacientes.

[Joel Poder @JPoderMedPhys]

@dr_alimuhammad @Arsenal @Arsenalnewschan North London forever!

[Joel Poder @JPoderMedPhys]

@HimanshuNagarMD @TylerSbrt @piet_ost @DrStish This is a fair bar to set. Also working on making the juicing process easier!

[Joel Poder @JPoderMedPhys]

@sandraturner49 @JulieMcCrossin @caro_acro_ca Congratulations!

[Joel Poder @JPoderMedPhys]

@PBlanchardMD Is this from the Quebec group?

[Joel Poder @JPoderMedPhys]

Huge thank you to all collaborators, participating institutions, and international brachytherapy societies who helped distribute and support the survey.

Publication available here:

https://t.co/9KTxGbrlG7

#Brachytherapy #RadiationOncology #MedicalPhysics #RadOnc

[Joel Poder @JPoderMedPhys]

Happy to share that the first manuscript from the ENCOMPASS prostate brachytherapy consortium has now been published in @BrachyJournal

https://t.co/024FHdtyEc

@PBlanchardMD @MarioTerlizziFR @agomeziturriaga @DrAmanTaggar @ArjitB_medphys

[Joel Poder @JPoderMedPhys]

This type of work is helping inform the development of larger international collaborative initiatives under ENCOMPASS, focused on outcomes, workflows, imaging, dosimetry, and quality assurance in prostate brachytherapy.

[Joel Poder @JPoderMedPhys]

@PBlanchardMD @piet_ost @CTuscanoMD @CedricPetersRT While not great it might be the best tool that we have? I’m not aware of any better alternatives. We as a community are now starting to use it heavily in the reirradiation setting also (in general not just in prostate)…

[Joel Poder @JPoderMedPhys]

@TylerSbrt @TylerSbrt7 @APCCC_Lugano @OncoAlert @Silke_Gillessen @AOmlin Amazing!

[Joel Poder @JPoderMedPhys]

@DrStish @jryckman3 @5_utr @TylerSbrt7 @cpeedell @SeibertLab @IJROBP @RO_GreenJournal @ARRO_org @ASTRO_org @ESTRO_org @CZamboglou @alison_tree @DrSpratticus @subatomicdoc @PBlanchardMD @DrAndrewLoblaw @SbrtSean @NehaVapiwala @piet_ost @seanmmcbride My dept just did a planning study comparing HDR vs. SBRT boost. N=20. If considering max doses as constraint for rectum/urethra, and lesions are close then both are equiv (at least on the screen). If not abutting OAR, brachy superior dosimetrically

[Joel Poder @JPoderMedPhys]

@VedangMurthy @jryckman3 @yuanjamesrao @SimranGula45676 Will definitely keep an eye out

[Joel Poder @JPoderMedPhys]

@VedangMurthy @jryckman3 @yuanjamesrao @SimranGula45676 Interested to see the results. My thoughts have always been that for PORT it shouldn’t matter but for WPRT it will

[Joel Poder @JPoderMedPhys]

@cristian_udo @ndesai2005 @DrAndrewLoblaw Absolutely, apologies if previous posts have come across as rude. No mean feat to follow these patients for 10 years.

For me, shows lack of long term HDR brachy data in multi-institutional setting. We need to follow your lead and do better!

[Joel Poder @JPoderMedPhys]

Congratulations @cristian_udo and co-authors on putting this together.

Hard to take too much away given the differences in how toxicity was collected amongst SBRT studies and only 1 brachytherapy trial included from single site.

We need more data before making conclusions

[Dr. Andrew Loblaw @DrAndrewLoblaw]

Curious about whether #SBRT or #brachy is better treatment for intermediate risk prostate cancer?

See @cristian_udo @JAMANetworkOpen article just posted!

JAMANetworkOpen.2026;9(2):e260146. doi:10.1001/jamanetworkopen.2026.0146

@DrSpratticus @AmarUKishan @nickva1 @alison_tree

[Joel Poder @JPoderMedPhys]

@MellyB_7 @DrewMoghanaki @TheASMR1 Missed you in this weeks SIGA meeting Melissa!

[Joel Poder @JPoderMedPhys]

@DrAndrewLoblaw Sunnybrook are world leaders in brachy. Have paved the way in multiple aspects